Détails sur le projet
Description
DESCRIPTION (provided by applicant): WARCEF-STAT and WARCEF-CLIN are two highly coordinated units which together constitute WARCEF, a two-arm (1:1) double-blind randomized multicenter clinical trial. Its primary aim is to test the primary null hypothesis of no difference between warfarin (INR 2.5-3, target 2.75) and aspirin (325 mg/day) therapies in time to the first to occur of death from any cause, ischemic stroke, or symptomatic non-fatal intracerebral hemorrhage (ICH) among patients with low (
| Statut | Terminé |
|---|---|
| Date de début/de fin réelle | 9/30/01 → 8/31/13 |
Financement
- National Institute of Neurological Disorders and Stroke: 5 534 164,00 $ US
- National Institute of Neurological Disorders and Stroke: 2 081 306,00 $ US
- National Institute of Neurological Disorders and Stroke: 1 000 000,00 $ US
- National Institute of Neurological Disorders and Stroke: 2 043 118,00 $ US
- National Institute of Neurological Disorders and Stroke: 1 684 927,00 $ US
- National Institute of Neurological Disorders and Stroke: 2 168 405,00 $ US
- National Institute of Neurological Disorders and Stroke: 200 000,00 $ US
- National Institute of Neurological Disorders and Stroke: 2 607 698,00 $ US
- National Institute of Neurological Disorders and Stroke: 1 995 081,00 $ US
- National Institute of Neurological Disorders and Stroke: 1 982 994,00 $ US
Keywords
- Cardiología y medicina cardiovascular
Empreinte numérique
Explorer les sujets de recherche abordés dans ce projet. Ces étiquettes sont créées en fonction des prix/bourses sous-jacents. Ensemble, ils forment une empreinte numérique unique.